Plenary focus - April (Brussels mini-session)

When it comes to clinical trials we need more ethics, more transparency and more respect for human rights. We succeeded in our efforts to make the initial Commission proposal respect the rights of people involved in clinical trials, especially those belonging to vulnerable populations. The role of national ethics committees was restored, as a clinical trial cannot go ahead if the responsible ethics committee objects to it. In order to ensure transparency of results from clinical trials the outcome must be published on an EU portal, even if it is inconclusive.